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Abstract: This paper provides an overview of recently developed two dimensional (2D) 
fragment-based  QSAR  methods  as  well  as  other  multi-dimensional  approaches.  In 
particular, we present recent fragment-based QSAR methods such as fragment-similarity-
based  QSAR  (FS-QSAR),  fragment-based  QSAR  (FB-QSAR),  Hologram  QSAR 
(HQSAR), and top priority fragment QSAR in addition to 3D- and nD-QSAR methods 
such as comparative molecular field analysis (CoMFA), comparative molecular similarity 
analysis (CoMSIA), Topomer CoMFA, self-organizing molecular field analysis (SOMFA), 
comparative molecular moment analysis (COMMA), autocorrelation of molecular surfaces 
properties (AMSP), weighted holistic invariant molecular (WHIM) descriptor-based QSAR 
(WHIM), grid-independent descriptors (GRIND)-based QSAR, 4D-QSAR, 5D-QSAR and 
6D-QSAR methods. 
Keywords:  QSAR;  fragment  similarity  based;  fragment-based;  2D-QSAR;  3D-QSAR;  
nD-QSAR 
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1. Introduction 
Quantitative structure-activity relationship (QSAR) is based on the general principle of medicinal 
chemistry that the biological activity of a ligand or compound is related to its molecular structure or 
properties,  and  structurally  similar  molecules  may  have  similar  biological  activities  [1].  Such 
molecular  structural  information  is  encoded  in  molecular  descriptors  and  a  QSAR  model  defines 
mathematical relationships between descriptors and biological activities of known ligands to predict 
unknown ligands’ activities. QSAR methods have been applied in several scientific studies including 
chemistry, biology, toxicology and drug discovery to predict and classify biological activities of virtual 
or newly-synthesized compounds [2–6]. QSAR models can also be used in designing new chemical 
entities  (NCEs)  and  are  now  regarded  as  essential  tools  in  pharmaceutical  industries  to  identify 
promising hits and generate high quality leads in the early stages of drug discovery [5,7]. In other 
words,  QSAR  studies  can  reduce  the  costly  failures  of  drug  candidates  by  identifying  the  most 
promising hit compounds and reducing the number of costly experiments. 
In general, QSAR modeling (Figure 1) involves a systematic process with multiple steps, including 
dataset preparation, molecular descriptors selection and generation, mathematical or statistical models 
derivation,  model  training  and  validation  using  a  training  dataset  and  model  testing  on  a  testing 
dataset. During the first step, or dataset preparation, it is important to pay attention to the quality of 
data to develop a reliable QSAR model. Data should come from the same bioassay protocols and it is 
preferable to collect and use the data generated from a single lab or source in order to avoid data 
inconsistencies  and  interlaboratory  variability.  Moreover,  the  dataset  should  have  a  large  enough 
number of compounds to ensure statistical stability of a QSAR model and the bioactivity should cover 
a range of values with a good distribution [5]. The second step in QSAR modeling is the selection and 
generation of molecular descriptors for ligands in the dataset. There are many descriptors available and 
only some of them are significantly correlated with the activity. Therefore, selection of appropriate 
descriptors, which best capture the structural variation and information is important to derive a robust 
QSAR model. Several methods such as evolutionary algorithms (for example, genetic algorithm) and 
machine  learning  techniques  (for  example,  forward  selection)  can  be  used  for 
descriptor/variable/feature  selection.  After  molecular  descriptors  are  defined  and  generated  for  all 
ligands in the dataset, the next step is to decide a suitable statistical or mathematical model to find the 
relationship between such descriptors and biological activities. For instance, linear approaches such as 
multiple linear regression (MLR) or partial least square (PLS) and non-linear methods such as neural 
networks or support vector machine can be used as correlation or mapping functions. Once a model is 
chosen, it is then trained on a training dataset which contains a subset of randomly selected compounds 
from a known dataset, leaving the remaining to be used as testing compounds. During the model 
training, validation methods such as leave-one-out cross-validation (LOOCV) are often performed to 
ensure the statistical stability of the QSAR model. The training process is repeated until a satisfactory 
training performance is achieved. Finally, a testing process is performed in which the trained model is 
used to predict activity values of those compounds in the testing set.  
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Figure 1. A general scheme of a QSAR model development which includes systematic 
training and testing processes. 
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A wide range of QSAR methodologies have been invented since the concept was first introduced by 
Free, Wilson, Hansch, and Fujita [8,9] in 1964. Traditional 2D-QSAR methods such as Free -Wilson 
and  Hansch-Fujita  models  use  2D  molecular  substituents  or  fragments  and  their  physicochemical 
properties to perform quantitative predictions. Since then , QSAR has experienced a fast development 
and  the  fi rst  novel  3D -QSAR  method  called  comparative  molecular  field  analysis  (CoMFA)  was 
introduced by Cramer et al. in 1988. The CoMFA method brought a foundation for the development of 
other  3D-QSAR  methods  such  as  CoMSIA,  SOMFA,  CoMMA  as  well  as  multidimensional  
(nD)-QSAR methods such as 4D-QSAR, 5D-QSAR, etc., to tackle known 3D-QSAR problems such as Int. J. Mol. Sci. 2010, 11                       
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subjective molecular alignment and bioactive conformation problems. In recent years, fragment-based 
methods have attracted some attention because predicting molecular properties and activities based on 
molecular  fragments  is  simple,  fast  and  robust.  In  this  review,  we  present  recently  available  
fragment-based QSAR methods and multidimensional (nD)-QSAR methods developed over the past 
few decades. 
2. Fragment-Based 2D-QSAR Methods 
Over the years, improved methods—that are based on such traditional QSAR methods—have been 
introduced. 2D methods allow modeling of a wide variety of ligands or compounds including cases 
where 3D crystal receptor or target structures are not available [7].  
2.1. Hologram-QSAR (HQSAR) 
One  earlier  example  of  a  fragment-based  method  is  HQSAR  (Hologram  QSAR)  from  Tripos 
[10,11].  Given  a  method  based  on  2D  molecular  fragments,  HQSAR  does  not  require  molecular 
alignment and therefore allows for automated analyses of large data sets without manual intervention. 
The first step in the HQSAR method is to generate molecular holograms which contain counts of 
molecular fragments and can be related to 2D fingerprints. As depicted in Figure 2, the input dataset 
contains 2D structures of compounds and they are split into all possible linear and branched fragments. 
Then each unique fragment is assigned to a specific large positive integer by using a cyclic redundancy 
check (CRC) algorithm. All fragments generated are then hashed into array (hologram) bins in the 
range from 1 to L (total length of hologram). Bin occupancies represent counts of fragments in each 
bin.  In  other  words,  they  are  structural  descriptors,  which  contain  topological  and  compositional 
molecular information. During the second step, such fragment counts or hologram bins are correlated 
to corresponding biological activities (dependent variables) in a form of mathematical equation. Leave-
one-out  cross-validation  (LOOCV)  is  performed  to  identify  an  optimal  number  of  explanatory 
variables or components which yields an optimal model. Then by using standard partial least square 
(PLS) analysis, a following mathematical regression equation is derived to correlate hologram bin 
values or components with corresponding biological activities: 


 
L
j
j ij i C x const BA
1
            (1) 
where BAi is the biological activity of the i
th compound, xij is the occupancy value of the molecular 
hologram of the i
th compound at position or bin j, Cj is the coefficient for the bin j derived from the 
PLS analysis, and L is the length of the hologram. 
One drawback of HQSAR is a phenomenon called a fragment collision problem which happens 
during the hashing process of fragments. Although hashing reduces the length of the hologram, it 
causes  bins  to  have  different  fragments  in  the  same  bin.  The  hologram  length,  a  user-definable 
parameter, controls the number of bins in the hologram and alteration of hologram length can causes 
the pattern of bin occupancies to change. The program provides 12 default lengths which have been Int. J. Mol. Sci. 2010, 11                       
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found to give good predictive models on different datasets. Each of these default lengths provides a 
unique set of fragment collisions [11].  
Several HQSAR models for different ligand datasets including cases where the 3D crystal structure 
of  receptor  targets  or  proteins  are  unavailable  have  been  developed  in  recent  years  [12–15].  For 
example, HQSAR was used to study a set of 9-substituted-9-deazaguanine analogs which inhibit the 
human  purine  nucleoside  phosphorylase  (PNP)  enzyme.  HQSAR  was  used  to  identify  structural 
features with poor and favorable contributions towards molecular interactions in the active site [12]. In 
addition, HQSAR has been used in virtual screening to identify hits [16–18]. For instance, Salum et al. 
studied  a  set  of  180  indole  derivatives  having  potent  anticancer  activity.  They  developed  several 
HQSAR  models  and  compared  them  to  determine  optimal  cutoff  values  in  virtual  screening  
procedures [7]. 
Figure  2.  Hologram-QSAR  (HQSAR)  model  development,  which  includes  molecular 
hologram  generation  and  partial  least  square  analysis  to  derive  a  final  predictive  
HQSAR equation.  
Molecular Hologram Biological Activity
(pKi, pIC50, etc.)
0.3
0.2
Partial Least Square
Analysis
HQSAR model/equation


 
L
j
j ij i C x const Activity
1
2 8 3 7 5 6
2 8 3 7 5 7
 
2.2. Fragment-Based QSAR (FB-QSAR) 
Recently, Du et al. [19] introduced a 2D-QSAR method based on molecular fragments. The method 
uses a mixed Hansch-Fujita [9] linear free energy equation and Free-Wilson [8] equation. In particular, 
molecular fragments are first generated from ligands and the total binding free energy 
o
i G   between 
ligand i and the receptor is considered as the sum of contributions ∆gi,α from all fragments: Int. J. Mol. Sci. 2010, 11                       
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

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M
i
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i g b G
1
,

            (2) 
where ∆gi,α is the free energy contribution of fragment Fi,α and bα is a weight coefficient for each 
fragment. The binding free energy of a fragment, ∆gi,α, is described by a set of physical and chemical 
properties of the fragment: 


 
L
l
l i l i p a g
1
, , ,             (3) 
where pi,α,l is the l-th property of fragment Fi,α in molecule mi and al is the coefficient of l-th property 
of the fragment.  
In their studies, a total of 48 neuraminidase (NA) inhibitor analogs were used to train and test the 
model. Ten physicochemical properties were calculated for each substituent. Using an iterative double 
least square (IDLS) procedure, two sets of coefficients, one for fragments (bα from Equation 2) and 
another  for  physicochemical  properties  (al  from  Equation  3),  in  the  linear  equation  were  solved 
alternately and iteratively  until  the model met the convergence criterion. After 176 iterations,  the 
model converged and both sets of coefficients were solved. Such converged coefficients were used for 
the test calculation and the correlation coefficient (r) was 0.9525 (or r
2 = 0.91). They also tested on 
Free-Wilson  and  Hansch-Fujita  models,  which  achieved  r  values  of  0.2488  (r
2  =  0.06)  and  
0.9373 (r
2 = 0.88), respectively. The quantitative results proved the IDLS procedure enhanced the 
predictive power, and, given a novel method, more applications are necessary to fully explore its 
predictive potential. 
2.3. Fragment-Similarity Based QSAR (FS-QSAR)  
More recently, a fragment-similarity based QSAR (FS-QSAR) method [20] was developed to solve 
the major limitation of the original Free-Wilson method by introducing the fragment-similarity concept 
in the linear regression equation. Such a similarity concept was applied for the first time to improve the 
traditional Free-Wilson  equation instead of using physicochemical properties  which often produce 
non-unique solutions.  In this  approach, the  fragment similarity  calculation was  carried out  by the 
similarity. It used the lowest or highest eigen values calculated from BCUT-matrices [21,22], which 
contained  partial  charges  of  individual  atoms  and  their  atomic  connection  information  in  each 
individual fragments. The updated equation of the FS-QSAR is as follows: 
MSF
j
N
j
jg jk
P
k i A F F Sim const K
j
    


1
1
)}] , ( [max{ log          (4) 
N = the total number of substituent positions.  
Pj = the total number of possible substituents at the j
th substituent position.  
max = the max function picks the maximum score among similarity scores. 
Fjk = the k
th fragment (a known fragment in the training set) at the j
th substituent position.  
Fjg = a given fragment (the fragment from a testing/unknown compound) at the j
th substituent position. 
Sim[Fjk, Fjg] = the fragment similarity function compares Fjg to Fjk and calculates a similarity score. 
MSF
j A  = the coefficient of the most similar fragment (MSF) at the j
th substituent position. Int. J. Mol. Sci. 2010, 11                       
 
3852 
The similarity function used in Equation (4) is defined as: 
) ( ) (
) , (
jg jk
jg jk
F EV F EV
e F F Sim
 
       (5) 
where EV(Fjk) = lowest or highest eigen value of BCUT matrix of a fragment (Fjk). 
The algorithm was developed and then tested on different datasets including 83 COX2 analogs and 
85  triaryl  bis-sulfone  analogs.  For  statistical  modeling,  the  model  was  repeatedly  tested  on  five 
different testing sets which were generated by random selection of compounds. The average squared 
correlation coefficient, r
2, over five testing sets was 0.62 for COX2 analogs and 0.68 for bis-sulfone 
analogs. For comparison, the original Free-Wilson method was also tested, achieving the average r
2 
values of 0.46 for COX2 dataset and 0.42 for bis-sulfone dataset. Moreover, for better comparison the 
BCUT-similarity  function  was  replaced  by  Tanimoto  coefficient  (Tc)  method,  the  traditional  2D 
molecular similarity function, and the average r
2 was 0.62 for both COX2 and bis-sulfone analogs. The 
FS-QSAR  method  was  proved  to  have  an  effective  predictive  power  compared  to  the  traditional  
2D-QSAR  method  since  it  solved  the  major  limitation  of  the  original  Free-Wilson  method  by 
introducing the similarity concept into the regression equation. However, the predictive accuracy of 
FS-QSAR may not be as high as other higher dimension QSAR methods, but the method provides an 
objective, unique and reproducible 2D-QSAR model. 
2.4. Top Priority Fragment QSAR  
Casalegno et al. [23] introduced a fragment-based QSAR approach to predict pesticide aquatic 
toxicity to  the rainbow trout.  The method prioritizes  fragments’ contributions  to  toxicity  with  the 
assumption that one fragment  among others present  in  a compound  is mainly  responsible  for the 
toxicity. They used 282 carefully selected pesticides which were partitioned into 240 training and 42 
testing molecules. In the first stage, all 282 molecules were broken into small substructures or atomic 
centered units (ACUs). Then, a numerical criterion based on the training set toxicity data was applied 
to assign one fragment or top-priority fragment (TPF), made up of one or more ACUs, to each training 
molecule.  Once  the  TPFs  were  extracted,  a  ‘priority  matrix’  was  used  to  extract  all  priority 
relationships. A priority matrix contains information among training TPFs and can be used to find out 
which TPF has a priority to be assigned to a testing molecule. In the last stage, testing molecules were 
submitted to check for the presence of TPFs and information from the priority matrix was used to 
identify the ones(s) with highest priority, and final prediction was made based on average fragment 
toxicity.  The  final  r
2  for  the  training  set  was  0.85  and  0.75  for  the  test  set  proving  the  model’s 
effectiveness. 
2.5. Other Fragment-Related QSAR Studies 
In  recent  years,  some  new  fragment-based  QSAR  methods  have  been  discovered  as  well  as 
applications to biological interests. Zhokhova et al. [24] introduced a method which uses fragmental 
descriptors with labeled atoms and applied it to their QSAR/QSPR (quantitative structure-property 
relationship)  studies.  In  their  approach,  the  fast  stepwise  multiple  linear  regression  (FSMLR)  and 
three-layer artificial neural network (ANN) methods implemented in the NASAWIN program [25] Int. J. Mol. Sci. 2010, 11                       
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were  used  to  generate  fragmental  descriptors  with  labeled  atoms  and  to  construct  QSAR/QSPR 
models.  Andrade  et  al.  [26]  used  HQSAR  and  other  2D-QSAR  programs  to  study  a  series  of 
hydrazides as antituberculosis agents. They used DRAGON 5.4 [27], BuildQSAR [28], PIROUETTE 
[29] programs for generation and selection of 2D molecular descriptors. Tsygankova et al. [30] also 
did the QSAR studies of barbituric acid derivatives using 2D fragments as descriptors with different 
regression approaches such as step-by-step regression to construct correlation equations.  
3. 3D-QSAR 
The 3D-QSAR methods have been developed to improve the prediction accuracies of 2D methods. 
3D methods are computationally more complex and demanding than 2D approaches. In general, there 
are  two  families  of  3D-QSAR  methods:  alignment-dependent  methods  and  alignment-independent 
methods. Both families need experimentally or computationally derived bioactive conformations of 
ligands as templates for studies. Such 3D conformers are one of the most important factors to produce 
reliable  3D-QSAR  models  and  are  also  the  major  drawbacks  of  3D  methods.  Examples  of  both 
families are discussed below. 
3.1. Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices 
Analysis (CoMSIA) 
One of well-known methods is a three dimensional QSAR method called CoMFA developed by 
Cramer  et  al.  [31].  It  is  a  method  to  describe  3D  structure-activity  relationship  quantitatively  by 
considering 3D structures, and steric and electrostatic fields of ligands which are superimposed to 
generate such molecular fields. In other words, CoMFA is an alignment-dependent method in which 
molecular  field  interaction  energy  terms  are  correlated  with  biological  activities/responses  using 
multivariate statistical analyses. Figure 3 illustrates a general CoMFA modeling process where active 
molecules are first  placed in  a 3D  grid. Using a probe atom, steric and electrostatic energies are 
measured at each grid point for each molecule. Partial least square (PLS) analysis is then performed to 
correlate  such  field  energy  terms  to  activity  values  and  make  predictions.  Such  features  and 
calculations  make  CoMFA  an  improved  and  different  method  from  other  traditional  QSAR 
approaches. 
Another 3D QSAR method named CoMSIA by Klebe et al. is similar to CoMFA in terms of using a 
probe atom along grid points. However, additional molecular fields have been implemented in the 
CoMSIA approach. In particular, electrostatic, steric, hydrophobic, hydrogen bond acceptor (HBA), 
and hydrogen bond donor (HBD) properties are generated using a Gaussian distance function [32]. 
Using such  a  Guassian-type potential  function instead of  Lennard-Jones  and Coulombic functions 
provides accurate information at grid points for calculating molecular fields [33]. 
However, the major drawback of both methods is that all molecules have to be aligned and such 
alignment can affect the final CoMFA/CoMSIA model and predictions. A good alignment is necessary 
and quality of such alignment can be subjective, time-consuming [34] and CoMFA/CoMSIA models 
are  sometimes  non-reproducible  [33].  Nevertheless,  several  CoMFA/CoMSIA  models  have  been 
developed for many drug design and molecular modeling studies [6,35–39] Int. J. Mol. Sci. 2010, 11                       
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Figure 3. A general CoMFA workflow. 
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3.2. Topomer CoMFA  
Recently, Cramer et al. introduced a new QSAR method named the Topomer CoMFA [40] which is 
a rapid fragment-based 3D-QSAR method to predict significant R-groups, which can optimize the 
biological  activities as well as optimized structural changes  for lead scaffold hopping.  It uses the 
compound  library  collection  as  a  source  of  molecular  fragments  to  identify  such  substituents  or  
R-groups. The Topomer CoMFA method, unlike CoMFA, does not require the subjective alignment of 
3D ligand conformers and uses automated alignment rules. A topomer describes both a conformation 
and orientation of a molecular fragment and it is generated based on 2D structure without any relation 
to a receptor site or other ligands [34,40]. After such topomers are generated, CoMFA analysis is then 
carried out where electrostatic and steric fields are calculated using a probe atom around the 3D grid. 
Subsequently, partial least square (PLS) with leave-one-out cross-validation is performed to generate a 
predictive model. 15 3D-QSAR analyses retrieved from the literature yielded an average q
2 of 0.520 
compared  to  literature  average  q
2  of  0.636  [40].  Topomer  CoMFA  has  the  potential  to  optimize 
biological activities of ligands via fragments and has been used in lead-optimization and R-groups 
virtual screening studies [34,40] 
3.3. Self-Organizing Molecular Field Analysis (SOMFA) 
Robinson et al. [41] introduced another alignment-dependent 3D-QSAR method called SOMFA, 
which is based on both molecular shape and electrostatic potentials. Briefly, 3D grids are created as in 
other 3D-QSAR methods and for each grid point, molecular shape and electrostatic potential values 
are calculated. Shape values are binary meaning 1 for being inside the van der Waals envelope and 0 
outside. The key step is that the electrostatic potential value at each grid point is multiplied by the 
mean centered activity for that molecule as a weighing factor which causes the most active and least 
active molecules to have higher values than other common and less interesting molecules which are 
closer to the mean activity. The SOMFA grid value at a given x,y,z is defined as: 
Activity _ Centered _ Mean ) z , y , x ( operty Pr SOMFA
Set _ Training
i
i z , y , x       (6) 
Using such a property master grid, an estimate of the activity of the i
th molecule as defined by a 
certain property can be derived as: 
 
x y z
z , y , x i i , property SOMFA ) z , y , x ( operty Pr SOMFA       (7) 
In the final stage, correlations between  calculated SOMFA property values (
i , property SOMFA ) and 
biological activities are derived via multiple linear regression and a final predictive model is produced. 
Robinson et al. tested the model using two datasets: 31 steroid compounds and 35 sulfonamides. The 
corresponding  correlation  coefficient values  (r
2) of 0.5776 (r = 0.76)  and 0.5329 (r  = 0.73) were 
achieved, respectively. Compared to other methods such as CoMFA [31], MS-WHIM [42] and few 
others on steroid dataset, SOMFA had the lowest standard deviation of errors of prediction (SDEP), 
which is the root-mean-square error of the predictions. In short, SOMFA is similar to CoMFA in terms 
of using grids and necessity of molecular alignment but is not as statistically rigorous as CoMFA [1], Int. J. Mol. Sci. 2010, 11                       
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as the SOMFA model is conceptually simple without heavy statistical elements such as partial least 
square (PLS). 
3.4. Alignment-Free 3D-QSAR Methods 
In the last few decades, other 3D-QSAR methods which do not rely on alignments were introduced. 
Some examples include autocorrelation of molecular surfaces properties (AMSP) [43], comparative 
molecular moment analysis (CoMMA) [44], WHIM (Weighted Holistic Invariant Molecular) method 
[45,46], Molecular surface (MS)-WHIM [42], and GRIND [47].  
3.4.1. Autocorrelation of Molecular Surfaces Properties (AMSP) 
Wagener et al. introduced the AMSP method to map the physical properties of ligands to a van der 
Waals  surface  and  individual  atoms,  respectively.  It  uses  a  3D  descriptor  based  on  spatial 
autocorrelation of molecular properties at distinct points on the molecular surface. The points  are 
randomly distributed to have a continuous surface and the autocorrelation coefficient is obtained by 
summing the products of property values at various pairs of points at particular distances. For a series 
of distance intervals (dlower, dupper), a vector of autocorrelation coefficients is obtained as follows: 
   
ij
upper ij lower j i upper lower d d d p p
L
d d A ) (
1
) , (      (8) 
where pi is the molecular property value at point i, pj is the molecular property value at point j and L is 
the total number of distances in the interval [43]. 
Therefore, the vector contains a compressed expression of the distribution of a property on the 
molecular surface. After autocorrelation vectors were obtained, a multilayer neural network was then 
trained using such vectors to derive a predictive model of biological activity of 31 steroid compounds. 
The correlation coefficient value, r, of 0.82 (r
2 = 0.6724) was achieved with a cross-validated r
2 of 
0.63. In summary, the advantages of such autocorrelation vectors are the facts that they are shown to 
be  invariant  to  translation  and  rotation  since  only  spatial  distances  are  used  and  have  condensed 
description of molecular surface. However, original information cannot be reconstructed from such 
condensed vectors and the pharmacophore nature of a ligand may not be clear or interpretable [43]. 
3.4.2. Comparative Molecular Moment Analysis (CoMMA) 
Silverman  et  al.  [44]  introduced the CoMMA  method, which calculates  the zeroth-,  first-, and 
second-order spatial moments of the charge (such as quadrupolar moments) and the mass distribution 
(such as moments of inertia). Such molecular moment descriptors may be classified in three different 
categories: descriptors relating solely to molecular shape, descriptors relating only to molecular charge 
and descriptors relating to both shape and charge. The authors calculated 13 such descriptors and used 
them in partial least square analysis to generate predictive QSAR models for 31 steroid compounds. A 
range  of  statistical  performance  was  obtained  depending  on  different  partial  charge  calculation 
methods used to derive electrostatic moments. Cross-validated r
2 values ranging from 0.412 to 0.828 
were obtained using electrostatic moment descriptors calculated from Gasteiger charges or Guassian 
molecular orbital ab initio methods. The results showed that using quantum chemistry calculation-Int. J. Mol. Sci. 2010, 11                       
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based moments produced better predictive models than using only Gasteiger charge-based moments. 
Despite CoMMA’s comparable statistical performances to CoMFA’s, there are some limitations which 
may account for the limited number of published CoMMA applications. One reason is that the value of 
these descriptors, which measures the displacement between the center of mass and center of dipole 
with  respect  to  the  principal  inertial  axes,  equals  infinity  for  symmetric  molecules  whose  dipole 
moment is zero [5].  
3.4.3. Weighted Holistic Invariant Molecular (WHIM) Descriptor-Based QSAR 
WHIM descriptors contain 3D molecular information such as molecular size, shape, symmetry and 
distribution  of  molecular  surface  point  coordinates  [45,46].  Molecular  surface  (MS)-WHIM  is  a 
WHIM-based  3D  descriptor  derived  directly  from  molecular  surface  properties  [42].  For  WHIM 
descriptors, two types of matrices are defined: a molecular matrix containing cartesian coordinates of 
the  n  atoms  and  diagonal  matrices  containing  the  weights  which  are  physicochemical  properties 
associated with the n atoms of the molecule [42]. Each element of the diagonal matrix is defined as: 
  




 
 n
1 i
i
n
1 i
k ik j ij i
jk
w
q q q q w
s         (9) 
where n is the number of atoms, wi is the weight of ith atom, qij is the j
th coordinate of the i
th atom and 
j q is the average of the j
th coordinates [45]. 
In this expression, atoms can be weighted by mass, van der Waals volume, atomic electronegativity, 
electrotopological  index  of  Kier  and  Hall,  atomic  polarizability  and  molecular  electrostatic  
potential [33]. Elements in each diagonal matrix are subjected to principal component analysis (PCA) 
to obtain the scoring matrix, which is used to calculate PCA eigen values and eigen value proportion. 
Such values and proportions are then correlated with the molecular size and shape, respectively. One 
major advantage of the WHIM approach is that it provides a 3D QSAR descriptor which is invariant to 
translation  and  rotation  of  3D  molecular  structures.  In  MS-WHIM,  properties  associated  with  the 
molecular surface points are used as different weighting schemes to compute statistical parameters. In 
particular, the unitary value and molecular electrostatic potential (MEP) are computed at each point of 
the Connolly molecular surface [48], and they are considered as weights. The unitary value contains 
information about the molecular surface shape and MEP provides the electrostatic information about 
the electron density distribution [42]. Although the WHIM approach is  not sensitive to molecular 
orientation, MS-WHIM descriptor values are affected by the facts that the Connolly surface points are 
dependent  on the 3D orientation of the molecule and indices  for different  weighting schemes  are 
sensitive  to  surface  point  density  [42].  The  authors  tested  both  WHIM  and  
MS-WHIM on 31 steroid compounds and achieved the SDEP (standard deviation error of prediction) 
values of 1.750 and 0.742, respectively while CoMFA’s SDEP was 0.837. The results suggested that  
MS-WHIM prediction performance was comparable to CoMFA’s. SDEP was defined as follows: Int. J. Mol. Sci. 2010, 11                       
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WHIM/MS-WHIM  descriptors  are  invariant  to  3D  molecular  orientation  but  both  method s, like 
other 3D-QSAR methods, rely on ligand  conformation, which may  be subjective if ligand -receptor  
co-crystal structures are not known for the target of interest. 
3.4.4. Grid-Independent Descriptors (GRIND)-Based QSAR 
In an attempt to provide alignment-free descriptors which are easy to understand and interpret, 
Pastor et al. introduced grid-independent descriptors [47]. The method utilizes specific probes such as 
the O probe (carbonyl oxygen) and N1 probe (amide nitrogen) to calculate molecular interaction fields 
(MIFs) at grid points. At each node of the grid, the energy between the probe and target ligand (E) is 
calculated as: 
lj hb es E E E E                 (11) 
where Ees is the electrostatic energy, Ehb is the hydrogen-bonding energy, and Elj is the Lennard-Jones 
potential energy [49]. 
In this method, electrostatic interactions, hydrophobic interactions, hydrogen bond acceptor and 
hydrogen bond donor fields are considered to get a set of positions which defines a ‘virtual receptor 
site’ (VRS). VRS regions are then encoded into GRIND via an auto- and cross-correlation transform 
so that those regions are no longer dependent upon their positions in the 3D space. In other words, 
autocorrelation descriptors of the fields are calculated and only the highest products of molecular 
interaction  energies  are  stored  while  others  are  discarded.  This  difference  is  responsible  for  the 
‘reversibility’ of GRIND and the descriptors can be back-projected in 3D space using another related 
program  called  ALMOND  [50].  The  statistical  performance  of  GRIND  is  comparable  to  other 
methods,  but  the  advantage  is  that  it  is  alignment-free  and  easy  to  interpret.  However,  bioactive 
conformations  of  ligands  are  valuable  information  to  derive  the  virtual  receptor  site  (VRS)  and 
limitations on such information may affect final predictive models like other 3D methods. 
3.5. Multi-Dimensional (nD) QSAR Methods 
Multi-dimensional (nD) QSAR methods are essentially extensions of 3D-QSAR methods. These 
methods incorporate additional physical characteristics or properties (or a new dimension) to tackle the 
drawbacks of 3D-QSAR methods. One example is 4D-QSAR by Hopfinger et al. [51] which samples 
molecular conformations and alignments during the generation of a QSAR model. While incorporating 
some CoMFA features, it introduces the fourth dimension, which is the conformational Boltzmann 
sampling,  and  enables  the  method  to  be  used  as  a  receptor-independent  (RI)  method  as  well  as 
receptor-dependent (RD) method in which the geometry of the receptor is known. It should be noted 
that their 4D-QSAR method does not solve the alignment problem but it allows a rapid evaluation of 
individual trial alignments [51]. Such 4D-QSAR implementation can be found in XMAP program 
[51,52]. Recently, it has been shown that 5D- and 6D-QSAR can be used for multiple representations 
of the receptor as well as its solvation states [53–55]. In the reported 5D-QSAR method, Vedani et al. Int. J. Mol. Sci. 2010, 11                       
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introduced  a  multiple  representation  of  induced-fit  hypotheses,  i.e.,  the  adaptation  of  the  receptor 
binding pocket to the individual ligand topology, as the fifth dimension. In other words, they generated 
a family of quasi-atomistic receptor surrogates [56] which are optimized by using a genetic algorithm. 
The binding energy was calculated as: 
fit induced strain ernal int ligand , solvation receptor ligand binding E E S T E E E           (12) 
where Eligand-receptor is the force field energy of the ligand-receptor interaction, Esolvation,ligand is the ligand 
desolvation energy, TS is the change in the ligand entrophy upon receptor binding, Einternal strain is the 
change in ligand internal energy upon receptor binding, and Einduced fit is the energy uptake required for 
adapting the receptor surrogate [54]. 
The 5D-QSAR method was tested on a set of 65 NK-1 receptor antagonists and a set of 131 Ah 
receptor ligands, achieving predictive r
2 values of 0.837 and 0.832, while 4D-QSAR model resulted in 
0.834 and 0.795, respectively [54]. They concluded that the binding affinities of new molecules were 
predicted more accurately with 5D-QSAR than with other lower dimension models. In the reported 
6D-QSAR model, the simultaneous consideration of different solvation models was introduced by 
mapping parts of the surface area with different solvent properties [55]. 3D, 4D, 5D and 6D models 
were explored as comparison studies and the results showed the 6D-QSAR model produced the best 
predictive r
2 of 0.885 [55]. Both 5D- and 6D-QSAR methods are implemented in the Quasar and 
VirtualToxLab software [56,57]. 
4. Comparison of 2D or Fragment-Based QSAR versus 3D or nD-QSAR Methods 
In general, the predictive quality of 3D-QSAR methods depends on several factors such as the 
quality of molecular alignments/superimpositions, and information on ligand bioactive conformations. 
Especially  molecular  superimpositions  are  subjective  and  ligand  bioactive  conformations  always 
remain  unclear  when  there  is  no  structural  information  on  the  corresponding  receptor-ligand 
complexes. Conventional CoMFA results may often be non-reproducible because the model depends 
on the orientation of alignment of molecules, which can be varied and subjective. Although various 
improved  methods  and  other  procedures,  which  were  discussed  earlier  in  the  paper,  have  been 
introduced to overcome major limitations of 3D-QSAR methods, i.e., subjective molecular alignment 
and  bioactive  conformation  problems,  many  of  them  still  require  manual  interventions  and 
superimpositions  [58,59].  From  this  prospect,  2D  fragment-based  QSAR  methods  have  certain 
advantages over multi-dimensional QSAR methods since fragment-based or 2D-QSAR methods are 
simple and robust and do not require subjective (or time consuming) molecular alignment or putative 
binding conformation or determination of 3D structures. However, the disadvantage is that some of 
2D-QSAR methods such as Hansch-Fujita method may provide non-unique solutions and the overall 
predictive quality may not be as good as some multi-dimensional methods which are computationally 
more complex and demanding. A summary of QSAR methods discussed in the paper is listed in Table 
1. It should be noted that the performance of each QSAR model depends on the choice of dataset and 
different datasets can result in different predictive q
2 or r
2 or SDEP values. Int. J. Mol. Sci. 2010, 11                       
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Table 1. Summary of different QSAR methods and source information. 
Method  nD  Dataset 
Statistical 
model  Performance  Reference/Website 
HQSAR  2D  21 Steroids  PLS 
q
2 = 0.71;  
r
2 = 0.85 [11] 
[11] 
http://www.tripos.com 
FB-QSAR  2D  48 NA analogs   IDLS 
r = 0.95  
(r
2 = 0.91) [19]  [19] 
FS-QSAR  2D 
85 bis-sulfone analogs; 
83 COX2 analogs  MLR 
r
2 = 0.68;  
r
2 = 0.62 [20]  [20] 
TPF-QSAR  2D  282 pesticides 
PM-based 
prediction  r
2 = 0.75 [23]  [23] 
CoMFA  3D 
21 Steroids 
54 HIV-1PR inhibitors 
PLS 
 
q
2 = 0.75; r
2 = 0.96 [11] 
q
2 = 0.68; r
2 = 0.69 [60] 
[31] http://www.tripos.com 
[60] 
CoMSIA  3D 
Thermolysin inhibitors 
54 HIV-1PR inhibitors  PLS 
q
2 = [0.59, 0.64] [32]
 
q
2 = 0.65; r
2 = 0.73 [60] 
[61,62] http://www.tripos.com 
[60] 
Topomer 
CoMFA  3D  15 datasets from literature  PLS  average q
2 = 0.636 [40]  [40] http://www.tripos.com 
SOMFA  3D 
31 steroids; 35 
sulfonamides  MLR  r
2 = 0.58; r
2 = 0.53 [41]  [41] 
AMSP  3D  31 steroids  MNN  q
2 = 0.63; r
2 = 0.67 [43]  [43] 
CoMMA  3D  31 steroids  PLS  q
2 = [0.41, 0.82] [44]  [44] 
WHIM  3D  31 steroids  PCA  SDEP = 1.750 [42] 
[45] 
http://www.vcclab.org/lab/indexhlp/whimdes.html  
MS-WHIM  3D  31 steroids  PCA  SDEP = 0.742 [42]  [42] 
GRIND  3D 
31 steroids 
175 hERG inhibitors 
PLS; PCA 
PLS; SVM 
q
2 = 0.64; SDEP = 0.26 [47] 
q
2 = 0.41; r
2 = 0.57; SDEP = 0.72 [63] 
[47] http://www.moldiscovery.com/soft_grid.php  
[63] 
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Table 1. Cont. 
Method  nD  Dataset 
Statistical 
model  Performance  Reference/Website 
4D-QSAR  4D 
20 DHFR inhibitors; 
42 PGF2a analogs;  
40 2-substituted 
dipyridodiazepione 
inhibitors 
33 p38-MAPK inhibitors 
PLS 
GL-PLS 
r
2 = [0.90, 0.95]; 
r
2 = [0.73, 0.86];  
r
2 = [0.67, 0.76] [51]
 
q
2 = [0.67, 0.85] [64] 
[51] http://www.seascapelearning.com/4DsgiSW/  
[64] 
5D-QSAR  5D 
65 NK-1 antagonists;  
131 Ah ligands  MLR 
r
2 = 0.84;  
r
2 = 0.83 [54] 
[54] 
http://www.biograf.ch  
6D-QSAR  6D 
106 estrogen  
receptor ligands  MLR 
q
2 = 0.90; 
r
2 = 0.89 [55] 
[55] 
http://www.biograf.ch  
HQSAR = Hologram QSAR 
FB-QSAR = Fragment-based QSAR 
FS-QSAR = fragment-similarity-based QSAR 
TPF-QSAR = Top priority fragment QSAR 
CoMFA = Comparative molecular field analysis 
CoMSIA = Comparative molecular similarity indices 
analysis    
SOMFA = Self-organizing molecular field analysis 
AMSP = Autocorrelation of molecular surface properties 
CoMMA = Comparative molecular moment analysis 
WHIM = Weighted holistic invariant molcular QSAR 
MS-WHIM = Molecular surface WHIM 
GRIND = Grid independent descriptor 
PLS = Partial least square 
IDLS = Iterative double least square 
PM = Priority matrix 
MNN = Multilayer neural networks 
MLR = Multiple linear regression 
PCA = Principal component analysis 
q
2 = cross-validated r
2 
SDEP = standard deviation of errors of prediction 
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5. Conclusion 
We  have  provided  an  overview  of  different  QSAR  methods  and  recent  development  in  
fragment-based approaches using selected studies as an illustration. Since each QSAR method has its 
own advantages and disadvantages, researchers should choose appropriate methods for modeling their 
systems. However, given a wide range of choices, it is a challenging task to pick appropriate models 
for one’s studies. This paper outlines many basic principles of new fragment-based QSAR methods as 
well  as  other  3D-  and  nD-  QSAR  models  and  illustrates  some  examples  which  may  be  helpful 
references to many researchers. 
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